Genmab A/S (GMAB) Earnings Date, Estimates & Call Transcripts $20.80 -0.42 (-1.98%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Genmab A/S Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 12EstimatedActual EPS (Nov. 6) $0.29 Missed By -$0.03 Consensus EPS (Nov. 6) $0.32 Genmab A/S posted Q3 2024 earnings on November 6, 2024, reporting an EPS of $0.29, which missed the consensus estimate of $0.32 by $0.03. Quarterly revenue was reported to be $816.10 million, below the consensus estimate of $838.20 million. With a trailing EPS of $1.03 and a P/E Ratio of 20.19, Genmab A/S's earnings are expected to grow 16.41% next year, from $1.28 to $1.49 per share. Conference CallConference Call TranscriptGMAB Upcoming EarningsGenmab A/S's next earnings date is estimated for Wednesday, February 12, 2025, based off prior year's reporting schedules. Get Genmab A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Genmab A/S and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGMAB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GMAB Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Genmab A/S Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$1.28 EPSNext Year EPS Consensus Estimate: $1.49 EPS Genmab A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/12/2025(Estimated)-------11/6/2024Q3 2024$0.32$0.29 -$0.03$0.29$838.20M$816.10M8/8/2024Q2 2024$0.29$0.22 -$0.07$0.13$734.60M$779.50M5/2/2024Q1 2024$0.16$0.16-$0.03$594.23M$603.30M2/14/2024Q4 2023$0.34$0.36+$0.02$0.58$678.14M$675.29M11/7/2023Q3 2023$0.34$0.47+$0.13$0.47$657.79M$692.80M8/3/2023Q2 2023$0.31$0.30 -$0.01$0.30$618.77M$613.43M5/10/2023Q1 2023$0.09$0.05 -$0.04$0.05$417.27M$411.37M2/22/2023Q4 2022$0.35$0.12 -$0.23$0.12$634.17M$717.54M Genmab A/S Earnings - Frequently Asked Questions When is Genmab A/S's earnings date? Genmab A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based off last year's report dates. Learn more on GMAB's earnings history. What guidance has Genmab A/S issued on next quarter's earnings? Genmab A/S issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $3.1 billion-$3.2 billion, compared to the consensus revenue estimate of $3.1 billion. Did Genmab A/S beat their earnings estimates last quarter? In the previous quarter, Genmab A/S (NASDAQ:GMAB) missed the analysts' consensus estimate of $0.32 by $0.03 with a reported earnings per share (EPS) of $0.29. Learn more on analysts' earnings estimate vs. GMAB's actual earnings. How can I listen to Genmab A/S's earnings conference call? The conference call for Genmab A/S's latest earnings report can be listened to online. Listen to Conference Call How can I read Genmab A/S's conference call transcript? The conference call transcript for Genmab A/S's latest earnings report can be read online. Read Transcript How much revenue does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded annual revenue of $2.39 billion. How much profit does Genmab A/S generate each year? Genmab A/S (NASDAQ:GMAB) has a recorded net income of $631.91 million. GMAB has generated $1.03 earnings per share over the last four quarters. What is Genmab A/S's price-to-earnings ratio? Genmab A/S (NASDAQ:GMAB) has a trailing price-to-earnings ratio of 20.19 and a forward price-to-earnings ratio of 16.25. The price/earnings-to-growth ratio is 0.59. What is Genmab A/S's EPS forecast for next year? Genmab A/S's earnings are expected to grow from $1.28 per share to $1.49 per share in the next year, which is a 16.41% increase. More Earnings Resources from MarketBeat Related Companies TAK Earnings Date ARGX Earnings Date BNTX Earnings Date TEVA Earnings Date BGNE Earnings Date VTRS Earnings Date ITCI Earnings Date MRNA Earnings Date SMMT Earnings Date RDY Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? This page (NASDAQ:GMAB) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
